A Clinical Trial to Assess the Efficacy of a Single-dose of AlphaWave® L-Theanine on Cognitive Function in Healthy Adults With Moderate Stress

The goal of this clinical trial is to to assess the efficacy AlphaWave® L-Theanine on mental acuity/cognitive function and stress relief in healthy adults with moderate stress. The main question it aims to answer is: Is there a difference in change in mental acuity from pre- to post-dose between AlphaWave® L-Theanine and placebo? Participants will asked to provided a single dose of one capsule of a single dose of one capsule of AlphaWave® L-Theanine or one placebo capsule with 250 ml of room temperature water, and asked to complete tasks to assess cognitive function.

NCT Number	NCT07004023
Lead Sponsor	Ethical Naturals, Inc. Collaborators: KGK Science Inc.
Conditions	Cognitive Function, Moderate Stress
Enrollment	40 participants
Start Date	2025-11-29
Primary Completion	2026-05-06 (estimated)
Study Completion	2026-05-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-08